Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report
This case highlights the importance to consider severe paucisymptomatic or asymptomatic hypocalcemia as a possible side effect in bone-metastatic patients treated with denosumab. It is advisable to monitor serum calcium levels even in the absence of typical hypocalcemia-related symptoms.
Authors
- Andrea Corsello (ORCID: https://orcid.org/0000-0001-8167-4338)
- Francesco Torino (ORCID: https://orcid.org/0000-0001-5828-4438)
- Rosa Maria Paragliola (ORCID: https://orcid.org/0000-0002-5070-7771)
- Domenica D'Addario
- Annapina De Rosa
- Celestina Cannarsa
Institutions
- University of Rome Tor Vergata (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Agenzia Regionale Sanitaria della Puglia (IT)
- Ospedale degli Infermi (IT)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2024-12-06
- DOI
- https://doi.org/10.2174/0118715303347379241107095529
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00